Immunoglobulin light chain amyloidosis: 2013 update on diagnosis, prognosis, and treatment

Renal Transplantation in Systemic Amyloidosis-Importance of Amyloid Fibril Type and Precursor Protein Abundance

(2012) J. H. Pinney et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Cyclophosphamide-bortezomib-dexamethasone (CyBorD) produces rapid and complete hematologic response in patients with AL amyloidosis

(2012) J. R. Mikhael et al.   BLOOD

Cyclophosphamide, bortezomib, and dexamethasone therapy in AL amyloidosis is associated with high clonal response rates and prolonged progression-free survival

(2012) C. P. Venner et al.   BLOOD

A phase 1/2 study of lenalidomide with low-dose oral cyclophosphamide and low-dose dexamethasone (RdC) in AL amyloidosis

(2012) E. Kastritis et al.   BLOOD

Activity of pomalidomide in patients with immunoglobulin light-chain amyloidosis

(2012) A. Dispenzieri et al.   BLOOD

Lenalidomide, cyclophosphamide, and dexamethasone (CRd) for light-chain amyloidosis: long-term results from a phase 2 trial

(2012) S. K. Kumar et al.   BLOOD

Incidence and survival in non-hereditary amyloidosis in Sweden

(2012) Kari Hemminki et al.   BMC PUBLIC HEALTH

Ten-year survival after autologous stem cell transplantation for immunoglobulin light chain amyloidosis

(2012) Stefan Cordes et al.   CANCER

Safety and Efficacy of Triplet Regimens in Newly Diagnosed Light Chain Amyloidosis

(2012) Ajai Chari et al.   Clinical Lymphoma Myeloma & Leukemia

New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes

(2012) Giovanni Palladini et al.   JOURNAL OF CLINICAL ONCOLOGY

Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements

(2012) Shaji Kumar et al.   JOURNAL OF CLINICAL ONCOLOGY

End-stage renal failure due to amyloidosis: outcomes in 490 ANZDATA registry cases

(2012) W. Tang et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Salvage therapy with lenalidomide and dexamethasone in patients with advanced AL amyloidosis refractory to melphalan, bortezomib, and thalidomide

(2011) Giovanni Palladini et al.   ANNALS OF HEMATOLOGY

Reliable typing of systemic amyloidoses through proteomic analysis of subcutaneous adipose tissue

(2011) F. Brambilla et al.   BLOOD

High-dose melphalan and peripheral blood stem cell transplantation for light-chain amyloidosis with cardiac involvement

(2011) S. Madan et al.   BLOOD

Outcome in Renal AL Amyloidosis After Chemotherapy

(2011) Jennifer H. Pinney et al.   JOURNAL OF CLINICAL ONCOLOGY

Amyloidosis: Pathogenesis and New Therapeutic Options

(2011) Giampaolo Merlini et al.   JOURNAL OF CLINICAL ONCOLOGY

Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation

(2011) S. M. S. Herrmann et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Molecular Imaging of Amyloidosis: Will the Heart Be the Next Target After the Brain?

(2011) Wengen Chen et al.   Current Cardiology Reports

Discordance between serum cardiac biomarker and immunoglobulin-free light-chain response in patients with immunoglobulin light-chain amyloidosis treated with immune modulatory drugs

(2010) Angela Dispenzieri et al.   AMERICAN JOURNAL OF HEMATOLOGY

Changes in serum-free light chain rather than intact monoclonal immunoglobulin levels predicts outcome following therapy in primary amyloidosis

(2010) Shaji K. Kumar et al.   AMERICAN JOURNAL OF HEMATOLOGY

Efficacy of the combination of bortezomib and dexamethasone in systemic AL amyloidosis

(2010) W. Lamm et al.   ANNALS OF HEMATOLOGY

Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature

(2010) Sergio Siragusa et al.   ANNALS OF HEMATOLOGY

Mass Spectrometric–Based Proteomic Analysis of Amyloid Neuropathy Type in Nerve Tissue

(2010) Christopher J. Klein et al.   ARCHIVES OF NEUROLOGY

Lenalidomide in combination with melphalan and dexamethasone in patients with newly diagnosed AL amyloidosis: a multicenter phase 1/2 dose-escalation study

(2010) P. Moreau et al.   BLOOD

Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical features

(2010) S. Kumar et al.   BLOOD

I don't know how to treat amyloidosis

(2010) M. A. Gertz   BLOOD

Treatment with intravenous melphalan and dexamethasone is not able to overcome the poor prognosis of patients with newly diagnosed systemic light chain amyloidosis and severe cardiac involvement

(2010) S. Dietrich et al.   BLOOD

A second course of high-dose melphalan and auto-SCT for the treatment of relapsed AL amyloidosis

(2010) K Quillen et al.   BONE MARROW TRANSPLANTATION

Trends in day 100 and 2-year survival after auto-SCT for AL amyloidosis: outcomes before and after 2006

(2010) M A Gertz et al.   BONE MARROW TRANSPLANTATION

Mass Spectrometry-Based Proteomic Diagnosis of Renal Immunoglobulin Heavy Chain Amyloidosis

(2010) S. Sethi et al.   Clinical Journal of the American Society of Nephrology

Pitfalls in the Diagnosis of Primary Amyloidosis

(2010) Cheng E. Chee et al.   Clinical Lymphoma Myeloma & Leukemia

Renal outcome and monoclonal immunoglobulin deposition disease in 289 old patients with blood cell dyscrasias: A single center experience

(2010) Piero Stratta et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Nodular senile pulmonary amyloidosis: a unique case confirmed by immunohistochemistry, mass spectrometry, and genetic study

(2010) Anja C. Roden et al.   HUMAN PATHOLOGY

Sustained improvement in cardiac function with persistent amyloid deposition in a patient with multiple myeloma-associated cardiac amyloidosis treated with bortezomib

(2010) Hiroya Tamaki et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Bortezomib With or Without Dexamethasone in Primary Systemic (Light Chain) Amyloidosis

(2010) Efstathios Kastritis et al.   JOURNAL OF CLINICAL ONCOLOGY

Bladder Amyloidosis

(2010) Adnan Javed et al.   JOURNAL OF UROLOGY

Autologous stem cell transplant for immunoglobulin light chain amyloidosis: a status report

(2010) Morie A. Gertz et al.   LEUKEMIA & LYMPHOMA

Recent Improvements in Survival in Primary Systemic Amyloidosis and the Importance of an Early Mortality Risk Score

(2010) Shaji K. Kumar et al.   MAYO CLINIC PROCEEDINGS

Systemic amyloidosis: a challenge for the rheumatologist

(2010) Federico Perfetto et al.   Nature Reviews Rheumatology

Kidney dysfunction during lenalidomide treatment for AL amyloidosis

(2010) R. Specter et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Amyloid in endomyocardial biopsies

(2010) Barbara Kieninger et al.   VIRCHOWS ARCHIV

Amyloid load in fat tissue reflects disease severity and predicts survival in amyloidosis

(2010) Ingrid I. van Gameren et al.   ARTHRITIS CARE & RESEARCH

Prognostic Significance of Strain Doppler Imaging in Light-Chain Amyloidosis

(2010) Jun Koyama et al.   JACC-Cardiovascular Imaging

Echocardiographic Evaluation of Cardiac Amyloid

(2010) Wendy Tsang et al.   Current Cardiology Reports

Prevalence and Origin of Amyloid in Kidney Biopsies

(2009) Hanna von Hutten et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Amyloid in bone marrow smears of patients affected by multiple myeloma

(2009) Fara Petruzziello et al.   ANNALS OF HEMATOLOGY

Left ventricular hypertrophy: Cardiac magnetic resonance may help differentiate amyloidosis from hypertrophic cardiomyopathy

(2009) Mikaël Mabru et al.   Archives of Cardiovascular Diseases

Role of High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation in Primary Systemic Amyloidosis: A Systematic Review

(2009) Rahul Mhaskar et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

High-Dose Chemotherapy with Autotransplantation in AL Amyloidosis: A Flawed Meta-analysis

(2009) Jayesh Mehta et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Weekly and twice-weekly bortezomib in patients with systemic AL amyloidosis: results of a phase 1 dose-escalation study

(2009) D. E. Reece et al.   BLOOD

Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens

(2009) J. A. Vrana et al.   BLOOD

Cardiac Amyloidosis

(2009) Harit V. Desai et al.   Cardiology in Review

Serum free light chain analysis may miss monoclonal light chains that urine immunofixation electrophoreses would detect

(2009) Saad P. Shaheen et al.   CLINICA CHIMICA ACTA

Identification of Amyloidogenic Light Chains Requires the Combination of Serum-Free Light Chain Assay with Immunofixation of Serum and Urine

(2009) G. Palladini et al.   CLINICAL CHEMISTRY

Currents Concepts on the Immunopathology of Amyloidosis

(2009) Anupama Bhat et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Primary localized cutaneous amyloidosis: a sign of immune dysregulation?

(2009) Maurice J. Dahdah et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Cardiac amyloidosis in a patient with multiple myeloma: A case report and review of literature

(2009) David Sedaghat et al.   JOURNAL OF CLINICAL ULTRASOUND

Serum Uric Acid: Novel Prognostic Factor in Primary Systemic Amyloidosis

(2009) Shaji Kumar et al.   MAYO CLINIC PROCEEDINGS

Treatment of immunoglobulin light chain amyloidosis

(2009) Morie A. Gertz et al.   Current Hematologic Malignancy Reports

Practice Parameter: The Evaluation of Distal Symmetric Polyneuropathy: The Role of Autonomic Testing, Nerve Biopsy, and Skin Biopsy (An Evidence-Based Review)

(2009) J.D. England et al.   PM&R

Treatment of patients with advanced cardiac AL amyloidosis with oral melphalan, dexamethasone, and thalidomide

(2008) Giovanni Palladini et al.   ANNALS OF HEMATOLOGY

CD32B is highly expressed on clonal plasma cells from patients with systemic light-chain amyloidosis and provides a target for monoclonal antibody-based therapy

(2008) P. Zhou et al.   BLOOD

Predictors of survival in patients with systemic light-chain amyloidosis and cardiac involvement initially ineligible for stem cell transplantation and treated with oral melphalan and dexamethasone

(2008) D. Lebovic et al.   BRITISH JOURNAL OF HAEMATOLOGY

Efficacy of bortezomib in systemic AL amyloidosis with relapsed/refractory clonal disease

(2008) A. D. Wechalekar et al.   HAEMATOLOGICA

Laryngeal Amyloidosis Causing Hoarseness and Airway Obstruction

(2008) Gregory J. Gallivan et al.   JOURNAL OF VOICE

International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

(2008) A Dispenzieri et al.   LEUKEMIA

Troponin T level as an exclusion criterion for stem cell transplantation in light-chain amyloidosis

(2008) Morie Gertz et al.   LEUKEMIA & LYMPHOMA

High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Amyloidosis: 2008 BMT Tandem Meetings (February 13-17, San Diego)

(2007) Angela Dispenzieri et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION